Stifel Closes Acquisition of Torreya Partners

Rhea-AI Summary

Stifel Financial Corp. (NYSE: SF) announced the successful acquisition of Torreya Partners LLC, enhancing its global healthcare capabilities. This strategic move consolidates Stifel's position as a leading healthcare franchise and aims to improve cross-border investment banking services across North America, Europe, and Asia. Torreya, known for its expertise in life sciences, including biotechnology and pharmaceuticals, joins Stifel to provide comprehensive advisory services, including M&A, divestitures, and capital raising. The combined team has experience in approximately 700 M&A transactions since 2010, bolstering Stifel’s market presence significantly.

Positive

• Acquisition of Torreya Partners enhances global healthcare capabilities.
• Strengthens Stifel's investment banking services with an established life sciences expertise.
• Access to Torreya's advisory expertise across various financial transactions including M&A and capital raising.
• Combination of teams will improve cross-border service in complex healthcare transactions.

Negative

• None.

ST. LOUIS, March 01, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the completion of its acquisition of Torreya Partners LLC (“Torreya”), further solidifying its position as a top global healthcare franchise. The Stifel Global Healthcare Group, resulting from the combination, will operate with investment banking professionals serving clients throughout North America, Europe, and Asia in a sector that demands cross-border capabilities and international reach.

“Today marks another milestone for Stifel as we build on our leadership position across healthcare,” said Brad Raymond, Stifel Global Head of Investment Banking. “Torreya has built an outstanding reputation in the marketplace and demonstrated a keen ability to innovatively structure transactions to drive successful outcomes for clients, even in the most complex situations. I am thrilled to welcome the Torreya team to Stifel.”

Founded in 2007, Torreya brings to Stifel a deep specialization within life sciences, including biotechnology and pharmaceuticals. In addition to its core M&A business, Torreya also bolsters the Stifel platform through significant advisory expertise across divestitures and joint ventures, royalty monetization, licensing agreements, and private capital raising.

“We are excited to join the Stifel platform,” added Tim Opler, Torreya Managing Director and Co-Founder. “Together, we are better equipped to advise clients across their full lifecycle and entire spectrum of advisory needs.”

Led by Co-Heads Mark Dempster and Declan Quirke, the Stifel Healthcare Investment Banking Team has advised on approximately 700 total M&A and capital-raising transactions since 2010. Stifel’s presence in the healthcare sector goes well beyond investment banking, and includes a dedicated equity research offering (15 publishing analysts covering 245 companies worldwide), a dedicated specialist sales force, and a flagship annual Healthcare Conference, which attracts nearly 1,000 industry participants.

Stifel Company Information
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.

Cautionary Note Regarding Forward-Looking Statements
The information contained in this press release contains certain statements that may be deemed to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements in this report not dealing with historical results are forward-looking and are based on various assumptions. The forward-looking statements in this report are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by the statements. Material factors and assumptions could cause actual results to differ materially from current expectations. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. The Company disclaims any intent or obligation to update these forward-looking statements.

Media Contact
Neil Shapiro, (212) 271-3447
shapiron@stifel.com

Investor Relations Contact
Joel Jeffrey, (212) 271-3610
investorrelations@stifel.com

FAQ

What is the significance of Stifel's acquisition of Torreya Partners?

The acquisition strengthens Stifel's position in the global healthcare market, enhancing its investment banking services and advisory capabilities.

How will the Torreya acquisition impact Stifel's stock symbol SF?

The acquisition is expected to positively influence Stifel's growth and revenue potential, potentially enhancing stock performance over time.

When was the Torreya Partners acquisition completed by Stifel?

Stifel completed the acquisition of Torreya Partners on March 1, 2023.

What expertise does Torreya bring to Stifel Financial?

Torreya brings deep specialization in life sciences, including biotechnology and pharmaceuticals, along with significant advisory expertise in M&A and capital raising.

What strategic advantage does the Torreya acquisition provide Stifel?

The acquisition enhances Stifel's ability to offer comprehensive services in complex healthcare transactions and strengthens its international presence.